{
 "PrintNo":"A6067","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-03-08T14:56:26.619493Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-03-08","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"}],
 "Title":"Relates to labeling prescription bottles of opioids",
 "Summary":"Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug and that such drug may cause depression and overdose.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3333, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids",
 "SameAsPrintNo":"S4774-2021"
}